The global market for Synthetic Biology is estimated at US$15.3 Billion in 2023 and is projected to reach US$86.2 Billion by 2030, growing at a CAGR of 28.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly.
The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.
The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly.
The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Oligonucleotides & Synthetic DNA segment, which is expected to reach US$39.5 Billion by 2030 with a CAGR of a 29.3%. The Enzymes segment is also set to grow at 27.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $5.5 Billion in 2023, and China, forecasted to grow at an impressive 32.3% CAGR to reach $8.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Synthetic Biology Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Synthetic Biology Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Synthetic Biology Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Amyris, Inc., Agrivida, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 141 Featured):
- Agilent Technologies, Inc.
- Amyris, Inc.
- Agrivida, Inc.
- ATG Biosynthetics GmbH
- Algentech SAS
- Arzeda
- AdvanceSyn
- Asimov, Inc.
- ArsenalBio
- Abiochem Biotechnology
- Accelerbiotics
- Antheia
- Ardra Bio
- Baccuico
- Absci Corp.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned
- Agilent Technologies, Inc.
- Amyris, Inc.
- Agrivida, Inc.
- ATG Biosynthetics GmbH
- Algentech SAS
- Arzeda
- AdvanceSyn
- Asimov, Inc.
- ArsenalBio
- Abiochem Biotechnology
- Accelerbiotics
- Antheia
- Ardra Bio
- Baccuico
- Absci Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 442 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 15.3 Billion |
| Forecasted Market Value ( USD | $ 86.2 Billion |
| Compound Annual Growth Rate | 28.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
